DNA repair in response to anthracycline–DNA adducts: A role for both homologous recombination and nucleotide excision repair
- 1 February 2008
- journal article
- Published by Elsevier BV in Mutation research. Reviews in mutation research
- Vol. 638 (1-2), 110-121
- https://doi.org/10.1016/j.mrfmmm.2007.09.005
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Formaldehyde in Human Cancer Cells: Detection by Preconcentration-Chemical Ionization Mass SpectrometryAnalytical Chemistry, 2001
- Mass Spectrometric Measurement of Formaldehyde Generated in Breast Cancer Cells upon Treatment with Anthracycline Antitumor DrugsChemical Research in Toxicology, 2000
- Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzymeBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Characterization of covalent Adriamycin-DNA adductsProceedings of the National Academy of Sciences of the United States of America, 1998
- Redox Pathway Leading to the Alkylation of DNA by the Anthracycline, Antitumor Drugs Adriamycin and DaunomycinJournal of Medicinal Chemistry, 1997
- Use of oligonucletides to define the site of interstand cross-links induced by AdriamycinNucleic Acids Research, 1995
- Formaldehyde crosslinks daunorubicin and DNA efficiently: HPLC and x-ray diffraction studiesBiochemistry, 1991
- Nucleotide sequence of SN-07 chromophore binding site.The Journal of Antibiotics, 1989
- New potent anthracyclines, barminomycins I and II.The Journal of Antibiotics, 1988
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984